MC
MET icon

Moors & Cabot’s MetLife MET Stock Holding History

Moors & Cabot’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$842K Sell
11,905
-165
-1% -$12.4K 0.04% 415
2025
Q4 		$953K Sell
12,070
-789
-6% -$62.4K 0.04% 367
2025
Q3 		$1.06M Buy
12,859
+662
+5% +$52.1K 0.05% 347
2025
Q2 		$981K Buy
12,197
+153
+1% +$11.8K 0.05% 343
2025
Q1 		$967K Sell
12,044
-89
-0.7% -$7.4K 0.05% 331
2024
Q4 		$993K Buy
12,133
+369
+3% +$30.7K 0.05% 337
2024
Q3 		$970K Sell
11,764
-507
-4% -$37.9K 0.05% 339
2024
Q2 		$861K Buy
12,271
+106
+0.9% +$7.57K 0.05% 337
2024
Q1 		$902K Sell
12,165
-673
-5% -$46.9K 0.05% 332
2023
Q4 		$849K Buy
12,838
+324
+3% +$20.3K 0.05% 311
2023
Q3 		$787K Sell
12,514
-2,597
-17% -$162K 0.05% 318
2023
Q2 		$854K Sell
15,111
-94
-0.6% -$5.22K 0.06% 300
2023
Q1 		$881K Sell
15,205
-1,301
-8% -$87.8K 0.06% 289
2022
Q4 		$1.19M Sell
16,506
-79
-0.5% -$5.66K 0.08% 240
2022
Q3 		$1.01M Sell
16,585
-31
-0.2% -$1.98K 0.08% 251
2022
Q2 		$1.04M Sell
16,616
-39
-0.2% -$2.58K 0.08% 258
2022
Q1 		$1.17M Buy
16,655
+37
+0.2% +$2.5K 0.07% 259
2021
Q4 		$1.04M Buy
16,618
+5,318
+47% +$334K 0.06% 277
2021
Q3 		$695K Buy
11,300
+1,803
+19% +$109K 0.04% 361
2021
Q2 		$568K Buy
9,497
+508
+6% +$32.2K 0.04% 387
2021
Q1 		$543K Sell
8,989
-1,594
-15% -$88K 0.04% 378
2020
Q4 		$498K Buy
10,583
+102
+1% +$4.42K 0.04% 370
2020
Q3 		$390K Sell
10,481
-445
-4% -$16.9K 0.04% 394
2020
Q2 		$402K Sell
10,926
-3,883
-26% -$135K 0.04% 369
2020
Q1 		$453K Sell
14,809
-7,135
-33% -$316K 0.07% 267
2019
Q4 		$1.11M Sell
21,944
-3,698
-14% -$179K 0.11% 191
2019
Q3 		$1.21M Sell
25,642
-1,492
-5% -$71.1K 0.13% 163
2019
Q2 		$1.34M Sell
27,134
-1,200
-4% -$56.4K 0.17% 140
2019
Q1 		$1.21M Buy
28,334
+65
+0.2% +$2.87K 0.16% 144
2018
Q4 		$1.16M Sell
28,269
-6,287
-18% -$270K 0.18% 137
2018
Q3 		$1.62M Buy
34,556
+447
+1% +$20.4K 0.2% 125
2018
Q2 		$1.49M Buy
34,109
+126
+0.4% +$5.87K 0.2% 130
2018
Q1 		$1.56M Buy
33,983
+6,563
+24% +$318K 0.21% 127
2017
Q4 		$1.39M Buy
27,420
+7,168
+35% +$378K 0.18% 133
2017
Q3 		$1.05M Buy
20,252
+69
+0.3% +$3.36K 0.15% 162
2017
Q2 		$979K Sell
20,183
-4,850
-19% -$225K 0.16% 163
2017
Q1 		$1.18M Sell
25,033
-16,442
-40% -$784K 0.2% 135
2016
Q4 		$1.99M Sell
41,475
-6,991
-14% -$321K 0.33% 80
2016
Q3 		$1.91M Buy
48,466
+10,686
+28% +$402K 0.32% 80
2016
Q2 		$1.34M Buy
37,780
+1,898
+5% +$74K 0.24% 114
2016
Q1 		$1.41M Buy
35,882
+18,217
+103% +$681K 0.25% 105
2015
Q4 		$758K Buy
17,665
+7,224
+69% +$318K 0.14% 185
2015
Q3 		$439K Sell
10,441
-668
-6% -$31.2K 0.08% 276
2015
Q2 		$552K Buy
11,109
+4,582
+70% +$217K 0.09% 269
2015
Q1 		$294K Buy
6,527
+823
+14% +$37K 0.05% 388
2014
Q4 		$274K Sell
5,704
-124
-2% -$5.89K 0.05% 399
2014
Q3 		$280K Sell
5,828
-2,565
-31% -$125K 0.05% 394
2014
Q2 		$417K Buy
8,393
+931
+12% +$43.6K 0.07% 309
2014
Q1 		$351K Buy
+7,462
New +$343K 0.09% 245

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Moors & Cabot's MET Position: Q1 2026 in Review

Moors & Cabot reduced its MetLife (MET) stake by 1.4% in Q1 2026, selling an estimated $12.4K and leaving 11,905 shares worth $842K. The position accounts for 0.04% of the portfolio, ranked #415.

Moors & Cabot first reported a position in MET in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.99M in Q4 2016. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Moors & Cabot held 11,905 shares of MetLife worth $842K as of Q1 2026.
  • Moors & Cabot sold 165 MetLife shares in Q1 2026, an estimated $12.4K.
  • MetLife made up 0.04% of Moors & Cabot's portfolio in Q1 2026, its #415 holding.
  • Moors & Cabot first reported a position in MetLife in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's MetLife position peaked at $1.99M in Q4 2016.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.